Keywords
GRADE, guidelines, Decision-making, methodology, scoping review
GRADE, guidelines, Decision-making, methodology, scoping review
Clinical guidelines are considered a key foundation for quality improvement in health care1. They are systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances1. The development of guidelines is intended to organize and provide the best available evidence to support clinical decision making in order to improve quality of care, patient outcomes, and cost-effectiveness.
Ideally, within a guideline, each recommendation will be presented with a rating of both its strength and the certainty of the underlying evidence. The guideline development groups (GDGs) charged with developing these recommendations generally comprise a mix of key clinical and non-clinical stakeholders. These diverse groups bring a plurality of experiences, perspectives, and backgrounds to the discussions informing evidence-based recommendations. However, this complexity can produce different interpretations of the same evidence by different stakeholders, as patients and physicians may process, interpret, and respond to various types of uncertainty inherent in clinical decisions in different ways2–4. Therefore, a systematic approach that helps groups consider all the relevant factors can facilitate a more structured and explicit process when developing recommendations5.
The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach, used internationally, presents a methodologically rigorous and transparent system for making judgments about the certainty of evidence and strength of recommendations6. The GRADE Evidence to Decision (EtD) framework (Table 1) was developed as a systematic and transparent way for guideline developers and decision makers to structure the process of moving from evidence to decisions, using pre-specified criteria5. These nine criteria (as outlined in Table 1) aim to ensure that important factors that determine a decision are considered in the decision-making process and a number of tailorable GRADE-EtD framework templates and guidance documents have been developed5,7,8. More than 100 organisations globally have adopted the principles of the GRADE system5, many of which include detail on using GRADE EtD in their methodological guidance documents9. Although GRADE has been widely endorsed, its use may be inconsistent with GRADE guidance and there is variation across organisations in terms of how the EtD should be adopted and applied9,10. The level of supporting evidence provided in published EtDs for core criteria such as resources required and cost effectiveness11, and equity12 has also been shown to vary.
The use of an EtD framework is associated with guidelines of better quality, and more credible and transparent recommendations13. It has been reported to help in structuring a complex process through relatively simple steps in an explicit and transparent way14, managing discussions, keeping guideline panels on track, and dealing with disagreements15. However, to take full advantage of the EtD framework, it is necessary to be familiar with the GRADE approach and the framework itself. Therefore, for new users, prior training may be helpful for successful use14. While numerous guidance documents have been developed5,7,8, emerging evidence has highlighted that there is variation in terms of how EtDs are being adopted and applied by organisations9,10. The first study assessing the use of GRADE's EtD framework during real-time guideline development using panel discussions found that the proportion of time dedicated to certain framework criteria (as outlined in Table 1) is greater than others (e.g. research evidence 53% versus equity 2%)16. Further studies have indicated that the level of supporting evidence provided in published EtDs for criteria such as resources required and cost effectiveness11, and equity12 has also been shown to vary. Factors contributing to this disparity were unclear.
Given the widespread use and endorsement, of the GRADE EtD approach and its potential to increase the quality of guidelines13, understanding how they are currently utilised and perceived may identify areas of variation and the contributing factors, as well as informing how best to provide training and support - an important facilitator of engagement, particularly for patients17. Therefore, this scoping review aims to identify the key characteristics of how the GRADE EtD is used and identify studies on perception of use by clinical guideline developers.
How do guideline development groups apply, populate, and perceive the GRADE EtD when developing recommendations in clinical guidelines?
Specific questions:
How is the GRADE EtD being used in GDG meetings in terms of the approaches to completing the EtD, guiding panel discussions and reaching consensus?
Are there studies on how the GRADE EtD is perceived by various stakeholders involved in GDGs?
How are the sections of the GRADE EtDs populated in terms of the research evidence and additional considerations supplied/cited to support developing recommendations?
The proposed scoping review will be conducted in accordance with the JBI methodology for scoping reviews18 and reported in line with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) extension for scoping reviews19. This scoping review aligns to the indication for conducting a scoping review in that it aims to identify key characteristics or factors related to a concept, including those related to methodological research20. The protocol has been registered with Open Science Framework21.
Participants. The focus of this review is on how GDGs apply the GRADE EtD, therefore participants in included studies will be guideline panel members, including but not limited to healthcare professionals, managers, methodologists, and patient representatives.
Concept. The concept of interest is how GDGs apply and perceive the GRADE EtD. This includes the approach to using the framework within panel meetings, how the framework is populated and with what sources, how it is presented and communicated, and the perspectives of those using the framework.
Context. This review will be limited to the inclusion of EtDs used in clinical guidelines. Guidelines can target any clinical area and can be at a local, national, regional, or global level. We will include guideline EtDs (provided in English) and evaluations. For guidelines that have been updated, only the most recent version will be included.
Types of documents. This scoping review will consider both peer reviewed published literature and grey literature. This will include empirical studies on the use of EtDs (including quantitative, qualitative, and mixed methods primary research articles) and discussion papers/ commentaries on the experience of using the EtD. Manuals and guidance documents on how to use the EtD, or articles describing its development or structure will not be included. Articles providing detailed descriptions of guidelines and the methodology to develop them will also be excluded. There will be no exclusions based on language or publication status (i.e., published, in press, in progress, or pre-print) for peer reviewed literature. For documents in languages other than English, Google Translate will be used, supplemented by interpretation by a native speaker where possible. Given the complexity of guideline EtDs and the potential for misinterpreting context, only EtDs produced in English will be included.
It will also include a random sample of populated EtDs (n=200) that have been made publicly available identified from databases and repositories of GRADE guidelines listed below. Given the number of published guidelines and EtDs published, it would not be feasible to include them all, therefore we have chosen an approach to restricting the numbers, as previous analyses have also done13. These guidelines can be created by any group but do need to have used a version of the GRADE EtD.
The search strategy, developed with an expert health librarian (PM), will aim to locate both published and unpublished documents. An initial exploratory search of Medline was undertaken to identify key articles on the topic. The terminology used within the articles was analysed and used to develop a full search strategy (Table 2) for both Medline and Embase (Elsevier), conducted April 2023. The search will be supplemented by a citation analysis of the seminal EtD papers.
The reference list of all included documents will be screened for additional studies using citationchaser22 supplemented by hand-searching reference lists where necessary.
The following databases, repositories, and websites will be filtered and screened for guideline EtDs, following the approach adopted in a scoping review of public health guidelines23:
the GIN international guideline library and registry of guidelines in development https://guidelines.ebmportal.com/
BIGG international database of GRADE guidelines https://sites.bvsalud.org/bigg/en/biblio/
Epistemonikos GRADE guidelines repository https://www.epistemonikos.org/en/groups/grade_guideline
GRADEpro Database of GRADE EtD’s and Guidelines https://gradepro.org/guidelines/
MAGICapp (https://app.magicapp.org/#/guidelines
Given the recency of the use of GRADE EtD (published in 2016), we will limit the search to an eight year span (2015–2023). The guideline authors will not be contacted; only information provided in the guidelines will be used. It is proposed to include a random sample of 200 (using a random number generator) of identified published EtDs, due to the feasibility of a very large volume being identified for inclusion.
Following the search, all identified citations will be collated and imported into Endnote X8. After deduplication, citations will be uploaded into Covidence. The title and abstracts will be screened independently by pairs of reviewers (so that each record is screened by at least two people) for assessment against the inclusion criteria for the review. The full text of selected citations will be assessed in detail against the inclusion criteria by two or more independent reviewers (so that each record is screened by at least two people) in Covidence. Reasons for exclusion of full texts will be recorded and reported. Any disagreements between the reviewers at each stage of the screening process will be resolved through discussion, or with an additional reviewer/s.
Using a standardized extraction form specifically designed for this review, we will conduct a pilot exercise using 10% of the sample (selected based on Covidence display, most relevant) for the data extractors to calibrate and test the review form. Each document will be extracted by pairs of reviewers working independently (so that each document is extracted by at least two people)
For included empirical studies, commentaries, and discussion papers (Table 3), data will be extracted on:
study characteristics (e.g., author, publication year, context, geographic setting)
study design (e.g., quantitative or qualitative) and approach to evaluation (e.g. survey, focus groups, interviews)
study participants (disciplines, amount)
description of application of EtD
evaluation outcome data
For included EtDs (Table 4), data will be extracted on:
the characteristics of the original guideline (e.g., authors, topic, setting)
the structure and application of the EtD
the type of evidence source/information used within each of the EtD criteria. Specifically, we will be interested in:
All included articles will be described in detail in tables and figures and summarised using descriptive statistics. Published EtDs will be analysed using summative content analysis24,25, aimed at identifying and quantifying which criteria are presented and the type of evidence source/information used.
At time of publication of this protocol, database searches have been carried out and title and abstract screening is currently underway.
We intend to disseminate the results through publication in a peer-reviewed journal and conference presentations. We will present our findings to professionals engaged in the development of clinical guidelines through the networks of the co-author team.
This scoping review aims to identify the key characteristics of how the GRADE EtD is used and identify studies on perception of use by clinical guideline developers. Given its widespread use and endorsement, it is important to evaluate the user experience of the GRADE-EtD framework. Understanding how GDG stakeholders perceive and use the EtD framework will inform how best to provide training and support - an important facilitator of engagement, particularly patient engagement.
The authors would like to thank Information Specialist Paul Murphy (RCSI University of Medicine and Health Sciences) for assistance with the development of the search strategy.
Is the rationale for, and objectives of, the study clearly described?
Yes
Is the study design appropriate for the research question?
Yes
Are sufficient details of the methods provided to allow replication by others?
Yes
Are the datasets clearly presented in a useable and accessible format?
Yes
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: My work involves the development of guidelines and clinical pathways. I have used both GRADE and EtD in my work.
Is the rationale for, and objectives of, the study clearly described?
Yes
Is the study design appropriate for the research question?
Yes
Are sufficient details of the methods provided to allow replication by others?
Yes
Are the datasets clearly presented in a useable and accessible format?
Not applicable
Competing Interests: I am an employee of NICE (UK) which produces health guidelines. NICE is an active user of GRADE and member of GRADE working groups, however NICE does not currently adopt the GRADE EtD framework in its guideline production process.
Reviewer Expertise: Health guideline methods, systematic reviewing, qualitative evidence synthesis
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | ||
---|---|---|
1 | 2 | |
Version 1 13 Sep 23 |
read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Register with HRB Open Research
Already registered? Sign in
Submission to HRB Open Research is open to all HRB grantholders or people working on a HRB-funded/co-funded grant on or since 1 January 2017. Sign up for information about developments, publishing and publications from HRB Open Research.
We'll keep you updated on any major new updates to HRB Open Research
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)